Sentynl Therapeutics, Inc.

Quick facts

Marketed products

• copper histidinate · Metabolic/Genetic Disorders
  Copper histidinate provides bioavailable copper to restore deficient copper levels in patients with copper malabsorption or deficiency.

Phase 2 pipeline

• Long Term Follow-Up

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sentynl Therapeutics, Inc. portfolio CI brief
• Sentynl Therapeutics, Inc. pipeline updates RSS